Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Executive Exclusives

Set Alert for Executive Exclusives and Hindsight 20/20

Hindsight 20/20: Mark Hitchman

Hindsight 20/20 is a Q&A feature where medtech industry veterans share their experience taking diverse businesses – be they start-ups or publicly listed entities – from strength to strength and navigating through times of crises. In this installment, Mark Hitchman, managing director of Canon Medical Systems Europe, shares insights on how to grow your business' market share and get that one-up over your competitors, as well as how to remain a market leader once you reach the top.

Hindsight 20/20 Diagnostic Imaging

Exec Chat: M Holland's Josh Blackmore On Plastics' Hard Impact On Medtech Innovation

Josh Blackmore recently joined M Holland Co., a leading distributor of thermoplastic resin, as its global healthcare manager to help expand the company's participation in the medical device industry. He provides insight on the importance of plastics and how this material plays an important role in helping to drive medical device-makers innovate.

Manufacturing Innovation

Exec Chat: Medtronic Diabetes VP Talks Value-Based Health Care

Medtronic Diabetes exec Suzanne Winter talks with Medtech Insight about her business' approach to value-based health care, including recently inked agreements with insurers such as Aetna and United Healthcare.

Market Access Reimbursement

Hindsight 20/20: Laurent Grandidier

Hindsight 20/20 is a Q&A feature where medtech industry veterans share their experience taking diverse businesses – be they startups or publicly-listed entities – from strength to strength and navigating through times of crises. In this installment, Laurent Grandidier shares what he learned from his time at medtech multinationals, like Teleflex and Boston Scientific, and at startups like Endosense and, the firm he currently leads, Xeltis. He explains how a carefully planned, step-by-step approach is the best way to get investors to buy into a high-risk, high-reward investment proposition, and why sometimes you need to have the audacity to pivot and take a company in a different, more commercially viable direction.

Hindsight 20/20 Business Strategies

Exec Chat: Johnson & Johnson Brings Together Physician Education Programs In The J&J Institute

Johnson & Johnson recently launched the Johnson & Johnson Institute – a network of 26 physician training education centers, putting what was previously an unconnected set of regional and specialty-specific education programs into one connected system to better serve J&J device-users in all geographies. Medtech Insight talked about the Institute, and its place within the diversified health-care giant, with Diana Bacci-Walsh, VP for North America Education Solutions for Johnson & Johnson Medical Devices.

Business Strategies Companies

Exec Chat: How B Braun Is Staying Ahead Of The APAC Game

B Braun Medical's Asia-Pacific operations has increasingly grown; sales from the region now makes up the third biggest chunk of the German multinational's annual revenue. But how does a mature company with an extensive portfolio of largely commoditized products stay nimble so it can adapt to a fast-changing and highly fragmented market like APAC? And how does it tackle potential headwinds like competition from local lower-cost manufacturers? Anna Maria Braun, president of B Braun's APAC business, speaks to Medtech Insight about how giving equal importance to every market in APAC – big or small – has helped the company's success in the region, and how innovation and collaboration will play an increasingly large role in ensuring continued growth.

Asia Pacific Business Strategies
See All
UsernamePublicRestriction

Register